Literature DB >> 8887276

Thiazide treatment of rats provokes apoptosis in distal tubule cells.

J Loffing1, D Loffing-Cueni, I Hegyi, M R Kaplan, S C Hebert, M Le Hir, B Kaissling.   

Abstract

We studied the effects of inhibition of apical NaCl entry on the structural correlates for electrolyte transport in the distal convoluted tubule (DCT) of rats. Thiazide diuretics were used to block NaCl entry specifically in the DCT. Metolazone or hydrochlorothiazide (HCTZ) were applied for three days subcutaneously via osmotic minipumps. The renal epithelial structure of control and treated rats was studied by light and electron microscopy. Distribution of the thiazide-sensitive NaCl cotransporter (rTSC1), calbindin D28K and Ca(2+)-Mg(2+)-ATPase was examined by immunohistochemistry, and the content of rTSC1 transcripts by Northern blot and in situ hybridization. In treated rats the DCT epithelium had lost the structural characteristics of electrolyte transporting epithelia and the cells were in different stages of apoptosis. In damaged cells calbindin D28K and Ca(2+)-Mg(2+)-ATPase were strongly decreased; the rTSC1 was shifted from the luminal membrane to the basal cell half and was found additionally in small membrane vesicles in intercellular and peritubular spaces. Transcripts of rTSC1 were drastically reduced in homogenates of kidney cortex and almost absent in damaged DCT cells. All other tubular segments were unaffected by the treatment. Focal inflammatory infiltrates were found to be specifically surrounding DCT profiles. Thus, inhibition by thiazides of apical NaCl entry into DCT cells is associated with apoptosis of DCT cells and focal peritubular inflammation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8887276     DOI: 10.1038/ki.1996.426

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  41 in total

Review 1.  Inflammation and therapy for hypertension.

Authors:  Cheryl L Laffer; Fernando Elijovich
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

2.  Antihypertensive therapy: beta-blockers and diuretics-why do physicians not always follow guidelines?

Authors:  F H Messerli
Journal:  Proc (Bayl Univ Med Cent)       Date:  2000-04

3.  Hypertension: Is there a dark side to thiazide therapy for hypertension?

Authors:  Takahiko Nakagawa; Richard J Johnson
Journal:  Nat Rev Nephrol       Date:  2010-10       Impact factor: 28.314

Review 4.  Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemia.

Authors:  Sirirat Reungjui; Thongchai Pratipanawatr; Richard J Johnson; Takahiko Nakagawa
Journal:  Curr Opin Nephrol Hypertens       Date:  2008-09       Impact factor: 2.894

Review 5.  Thiazide effects and adverse effects: insights from molecular genetics.

Authors:  David H Ellison; Johannes Loffing
Journal:  Hypertension       Date:  2009-06-29       Impact factor: 10.190

Review 6.  Distal convoluted tubule.

Authors:  James A McCormick; David H Ellison
Journal:  Compr Physiol       Date:  2015-01       Impact factor: 9.090

7.  Apoptosis of endothelial cells is associated with paracrine induction of adhesion molecules: evidence for an interleukin-1beta-dependent paracrine loop.

Authors:  M J Hébert; S R Gullans; H S Mackenzie; H R Brady
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

Review 8.  The mechanism of hypocalciuria with NaCl cotransporter inhibition.

Authors:  Robert F Reilly; Chou-Long Huang
Journal:  Nat Rev Nephrol       Date:  2011-09-27       Impact factor: 28.314

9.  High dose vitamin D3 attenuates the hypocalciuric effect of thiazide in hypercalciuric rats.

Authors:  Hye Ryoun Jang; Jay Wook Lee; Sejoong Kim; Nam Ju Heo; Jeong Hwan Lee; Hyo Sang Kim; Ji Yong Jung; Yun Kyu Oh; Ki Young Na; Jin Suk Han; Kwon Wook Joo
Journal:  J Korean Med Sci       Date:  2010-08-14       Impact factor: 2.153

10.  Impaired renal calcium absorption in mice lacking calcium channel beta 3 subunits.

Authors:  José F Bernardo; Clara E Magyar; W Bruce Sneddon; Peter A Friedman
Journal:  Can J Physiol Pharmacol       Date:  2009-07       Impact factor: 2.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.